[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100400873":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":31,"centralContacts":40,"locations":49,"responsibleParty":66,"collaborators":45,"id":69,"slug":70,"hasResults":71,"nctId":72,"briefTitle":73,"officialTitle":74,"acronym":45,"eligibilityCriteria":75,"healthyVolunteers":71,"sex":76,"minAge":77,"maxAge":45,"enrollmentInfo":78,"targetDuration":45,"studyType":81,"phases":82,"briefSummary":85,"conditions":86,"keywords":45,"overallStatus":52,"whyStopped":45,"lastUpdateSubmitDate":88,"lastUpdatePostDateStruct":89,"startDateStruct":92,"completionDateStruct":94,"leadSponsor":96,"locationsCount":97},{"fullName":5,"class":6},"Tanta University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"carvedilol","EXPERIMENTAL","Carvedilol",[13],"Drug: Carvedilol",{"label":15,"type":16,"description":15,"interventionNames":17},"Band Ligation","ACTIVE_COMPARATOR",[18],"Procedure: Endoscopic band ligation",[20,25],{"type":21,"name":11,"description":11,"armGroupLabels":22,"otherNames":23},"DRUG",[9],[24],"carvid",{"type":26,"name":27,"description":27,"armGroupLabels":28,"otherNames":29},"PROCEDURE","Endoscopic band ligation",[15],[30],"band ligation",[32,36],{"name":33,"affiliation":34,"role":35},"Asem Elfert, Prof","Tanta University - Faculty of Medicine","STUDY_DIRECTOR",{"name":37,"affiliation":38,"role":39},"Nabila Abd El-Nasser Abd El-Wahed El-Gazzar, ass. lect","Tanta University Faculty of medicine","PRINCIPAL_INVESTIGATOR",[41,47],{"name":42,"role":43,"phone":44,"phoneExt":45,"email":46},"Sherief Abd-Elsalam, ass. prof.","CONTACT","00201147773440",null,"sheriefabdelsalam@yahoo.com",{"name":48,"role":43,"phone":44,"phoneExt":45,"email":46},"Nabila el-gazzar, ass. lect.",[50],{"facility":51,"status":52,"city":53,"state":45,"zip":45,"country":54,"countryCode":55,"cosmosGeoPoint":56,"geoPoint":61,"contacts":62},"Sherief Abd-Elsalam","RECRUITING","Tanta","Egypt","EG",{"type":57,"coordinates":58},"Point",[59,60],31.00192,30.78847,{"lat":60,"lon":59},[63],{"name":64,"role":43,"phone":44,"phoneExt":45,"email":65},"sherief abd-elsalam, ass. prof","sheroefabdelsalam@yahoo.com",{"type":67,"investigatorFullName":51,"investigatorTitle":68,"investigatorAffiliation":5,"oldNameTitle":45,"oldOrganization":45},"SPONSOR_INVESTIGATOR","Ass. Prof. Tropical Medicine","100400873","phase-2-carvedilol-versus-endoscopic-band-ligation-for-primary-prophylaxis-of-oesophageal-variceal-bleeding-100400873",false,"NCT04499898","Carvedilol Versus Endoscopic Band Ligation for Primary Prophylaxis of Oesophageal Variceal Bleeding","Randomized Controlled Trial of Carvedilol Versus Endoscopic Band Ligation for Primary Prophylaxis of Oesophageal Variceal Bleeding in Cirrhotic Patients With Arterial Hypertension","Inclusion Criteria:\n\n* • Aged \\>18 years\n\n  * Cirrhotic patients with arterial hypertension\n  * Endoscopic evidence of medium\u002Flarge-sized esophageal varices\n\nExclusion Criteria:\n\n* • History of variceal bleeding or previous primary prevention of varices.\n\n  * Portal vein thrombosis or previous porto-systemic shunts as TIPS.\n  * Patients on drugs affecting portal pressure (beta blockers, nitrates).\n  * Advanced cardiovascular disease including acute myocardial infarction, atrio-ventricular block, congestive heart failure, chronic peripheral ischemia, severe bradycardia.\n  * Patients with severe respiratory diseases (COPD, bronchial asthma).\n  * Uncontrolled diabetes mellitus\n  * Renal impairment\n  * Hepatocellular carcinoma\n  * Allergy to carvedilol\n  * Pregnancy or lactation","ALL","18 Years",{"count":79,"type":80},306,"ESTIMATED","INTERVENTIONAL",[83,84],"PHASE2","PHASE3","Carvedilol versus endoscopic band ligation for primary prophylaxis of oesophageal variceal bleeding in cirrhotic patients with arterial hypertension",[87],"Esophageal Varices","2020-08-01",{"date":90,"type":91},"2020-08-05","ACTUAL",{"date":93,"type":91},"2018-10-01",{"date":95,"type":80},"2030-12-10",{"name":51,"class":6},1]